抗高血压药物临床试验中的新发糖尿病 - Suppr

Suppr

超能文献

Incident diabetes in clinical trials of antihypertensive drugs.

作者信息

Lam Simon Kh, Owen Andrew

机构信息

Department of Cardiology, Kent and Canterbury Hospital, Canterbury CT1 3NG, UK.

出版信息

Lancet. 2007 May 5;369(9572):1513-1514. doi: 10.1016/S0140-6736(07)60697-7.

DOI:10.1016/S0140-6736(07)60697-7

PMID:17482972

Abstract

摘要

相似文献

Incident diabetes in clinical trials of antihypertensive drugs.抗高血压药物临床试验中的新发糖尿病

Lancet. 2007 May 5;369(9572):1513-1514. doi: 10.1016/S0140-6736(07)60697-7.

Incident diabetes in clinical trials of antihypertensive drugs.

Lancet. 2007 May 5;369(9572):1514. doi: 10.1016/S0140-6736(07)60698-9.

New-onset diabetes mellitus less deadly than elevated blood pressure? Following the evidence in the administration of thiazide diuretics.新发糖尿病比高血压的致死性更低？循证使用噻嗪类利尿剂。

Arch Intern Med. 2006 Nov 13;166(20):2174-6. doi: 10.1001/archinte.166.20.2174.

Ethacrynic acid. A non-diabetogenic diuretic.

Pa Med. 1969 Aug;72(8):65-7.

Drug-induced new onset diabetes in hypertension: does it matter?

J Hypertens. 2007 Jun;25(6):1201-4. doi: 10.1097/HJH.0b013e32819f8536.

[Antihypertensive treatment in the type 2 diabetic].2型糖尿病患者的降压治疗

Nephrologie. 2000;21(4):203-4.

Diabetogenic effect of antihypertensive treatment: primum nil nocere.

Nephrol Dial Transplant. 2004 Mar;19(3):531-4. doi: 10.1093/ndt/gfg543.

Randomized clinical trials: prescriptions to be applied with caution!随机临床试验：应用时需谨慎！

Am J Hypertens. 2008 May;21(5):483-4. doi: 10.1038/ajh.2008.164.

[Blood pressure, antihypertensive agents and diabetes. Obese patients with hypertension are a high-risk group].

Lakartidningen. 1994 May 4;91(18):1810-1.

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).随机接受3种不同类别降压治疗的老年非糖尿病成年人的空腹血糖水平与新发糖尿病：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）的报告

Arch Intern Med. 2006 Nov 13;166(20):2191-201. doi: 10.1001/archinte.166.20.2191.

引用本文的文献

Effectiveness of the Combination of Enalapril and Nifedipine for the Treatment of Hypertension versus Empirical Treatment in Primary Care Patients.依那普利与硝苯地平联合治疗高血压对比基层医疗患者经验性治疗的疗效

J Cardiovasc Dev Dis. 2023 May 31;10(6):243. doi: 10.3390/jcdd10060243.

Systolic Blood Pressure and Risk of Type 2 Diabetes: A Mendelian Randomization Study.收缩压与2型糖尿病风险：一项孟德尔随机化研究

Diabetes. 2017 Feb;66(2):543-550. doi: 10.2337/db16-0868. Epub 2016 Oct 4.

Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.坎地沙坦高剂量和超高剂量对糖尿病小鼠肾脏的不同影响——ACE2/AT2R/Mas轴的潜在作用

Biosci Rep. 2016 Oct 27;36(5). doi: 10.1042/BSR20160344. Print 2016 Oct.

Gene expression in thiazide diuretic or statin users in relation to incident type 2 diabetes.噻嗪类利尿剂或他汀类药物使用者的基因表达与2型糖尿病发病的关系。

Int J Mol Epidemiol Genet. 2014 Feb 17;5(1):22-30. eCollection 2014.

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia.老年 2 型糖尿病的口服抗糖尿病治疗：平衡血糖控制的需求和低血糖风险。

Cardiovasc Diabetol. 2012 Oct 6;11:122. doi: 10.1186/1475-2840-11-122.

Low dose of hydrochlorothiazide, in combination with angiotensin receptor blocker, reduces blood pressure effectively without adverse effect on glucose and lipid profiles.低剂量氢氯噻嗪与血管紧张素受体阻滞剂联合使用可有效降低血压，且对血糖和血脂水平无不良影响。

Heart Vessels. 2013 May;28(3):316-22. doi: 10.1007/s00380-012-0246-5. Epub 2012 Mar 25.

Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study.瑞米普利为基础的与利尿剂为基础的抗高血压一线治疗在有前驱糖尿病（ADaPT）的患者研究。

Cardiovasc Diabetol. 2012 Jan 9;11:1. doi: 10.1186/1475-2840-11-1.

An overview of candesartan in clinical practice.坎地沙坦在临床实践中的概述。

Expert Rev Cardiovasc Ther. 2011 Aug;9(8):975-82. doi: 10.1586/erc.11.90.

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.坎地沙坦酯与氢氯噻嗪固定剂量复方制剂治疗高血压：患者观点及临床应用

Vasc Health Risk Manag. 2009;5:1043-58. doi: 10.2147/vhrm.s5549. Epub 2009 Dec 29.

Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care.在有心脏风险的患者中，血管紧张素II 1型受体阻滞剂联合氢氯噻嗪的代谢效应：一项初级保健中的非干预性研究

BMC Cardiovasc Disord. 2008 Nov 10;8:30. doi: 10.1186/1471-2261-8-30.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验